SG11201407446TA - Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy - Google Patents

Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Info

Publication number
SG11201407446TA
SG11201407446TA SG11201407446TA SG11201407446TA SG11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA
Authority
SG
Singapore
Prior art keywords
immunotherapy
peptides
peptide
combination
hydrochloride salt
Prior art date
Application number
SG11201407446TA
Other languages
English (en)
Inventor
Paul Laidler
Imre Farkas
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of SG11201407446TA publication Critical patent/SG11201407446TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201407446TA 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy SG11201407446TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208293A GB201208293D0 (en) 2012-05-11 2012-05-11 Hydrochlorice salt of peptide
PCT/GB2013/051201 WO2013167897A1 (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Publications (1)

Publication Number Publication Date
SG11201407446TA true SG11201407446TA (en) 2015-03-30

Family

ID=46396890

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407446TA SG11201407446TA (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Country Status (17)

Country Link
US (1) US9657061B2 (pt)
EP (1) EP2847209B8 (pt)
JP (1) JP5982562B2 (pt)
KR (1) KR20150014955A (pt)
CN (1) CN104428311B (pt)
AU (1) AU2013257784A1 (pt)
BR (1) BR112014028130A2 (pt)
CA (1) CA2873120A1 (pt)
EA (1) EA201492068A1 (pt)
GB (2) GB201208293D0 (pt)
HK (1) HK1201850A1 (pt)
IL (1) IL235388A (pt)
IN (1) IN2014DN09367A (pt)
MX (1) MX2014013394A (pt)
SG (1) SG11201407446TA (pt)
WO (1) WO2013167897A1 (pt)
ZA (1) ZA201408290B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
HUE056607T2 (hu) 2014-12-23 2022-02-28 Immatics Biotechnologies Gmbh Új peptidek és peptidkombinációk, hepatocelluláris karcinóma (HCC) és más rákok elleni immunoterápiában történõ alkalmazásra
GB201501017D0 (en) 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
ES2970246T3 (es) 2015-03-27 2024-05-27 Immatics Biotechnologies Gmbh Péptidos novedosos y combinación de péptidos para usarse en inmunoterapia contra diferentes tumores
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316632T3 (es) * 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
KR101728868B1 (ko) * 2006-01-18 2017-05-02 포시 파마슈티컬스 컴퍼니 리미티드 안정성이 강화된 약학 조성물
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
AU2008288283B2 (en) * 2007-08-15 2013-01-31 Circassia Limited Peptides for desensibilization against allergens
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
AU2011234264B2 (en) * 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material

Also Published As

Publication number Publication date
BR112014028130A2 (pt) 2017-08-15
GB201421491D0 (en) 2015-01-14
EP2847209B1 (en) 2020-08-05
JP5982562B2 (ja) 2016-08-31
CN104428311A (zh) 2015-03-18
GB2517354A (en) 2015-02-18
HK1201850A1 (en) 2015-09-11
AU2013257784A1 (en) 2014-11-20
CN104428311B (zh) 2019-11-01
US9657061B2 (en) 2017-05-23
EP2847209B8 (en) 2020-10-07
KR20150014955A (ko) 2015-02-09
JP2015517484A (ja) 2015-06-22
IL235388A (en) 2016-06-30
EA201492068A1 (ru) 2015-03-31
US20150110820A1 (en) 2015-04-23
CA2873120A1 (en) 2013-11-14
MX2014013394A (es) 2015-02-04
EP2847209A1 (en) 2015-03-18
ZA201408290B (en) 2016-01-27
GB201208293D0 (en) 2012-06-20
IN2014DN09367A (pt) 2015-07-17
WO2013167897A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
IL230918A0 (en) Modified proteins and peptides
HK1215934A1 (zh) 肽治療劑及其使用方法
ZA201308251B (en) Amino acid sequence presenting fusion polypeptide and its use
HK1199892A1 (en) Modified mini-hepcidin peptides and methods of using thereof
HK1200871A1 (en) Modified dna-binding proteins and uses thereof dna-
EP2850095A4 (en) INHIBITORS OF PEPTIDES AND PEPTIDOMIMETICS
IL279676A (en) Recombinant proteins and therapeutic uses
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
EP2721063A4 (en) PCSK9 BINDING POLYPEPTIDES AND METHOD OF USE THEREOF
HK1201850A1 (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
EP2720704A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2782589A4 (en) ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE
EP2738255A4 (en) PEPTIDE FROM ERAP1 AND ITS USE
ZA201400562B (en) Axmi205 variant proteins and methods for their use
EP2688579A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
HK1203161A1 (en) Peptides and methods of using same
EP2793921A4 (en) PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF
EP2796462A4 (en) ANTITUMOR PEPTIDE AND USE THEREOF
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
EP2742153A4 (en) PROTEIN AND PEPTIDE LIBRARIES
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
EP2918600A4 (en) NEW PEPTIDE AND ITS USE
GB201121236D0 (en) Proteins and peptides
GB201121226D0 (en) Modified proteins and peptides
GB201121233D0 (en) Modified proteins and peptides